Tech Company Financing Transactions
Clinical Ink Funding Round
Clinical Ink, based in Horsham, secured $9.9 million from F2 Ventures, FCA Venture Partners and MPM Capital.
Transaction Overview
Company Name
Announced On
3/19/2015
Transaction Type
Venture Equity
Amount
$9,860,223
Round
Undisclosed
Proceeds Purpose
The combination of Clinical Ink and CentrosHealth aims to create a clinical trial technology platform with the ability to conduct paperless clinical trials with purpose-built solutions for pharma companies, research sites, and patients.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
110 Gibraltar Rd. 150
Horsham, PA 19044
USA
Horsham, PA 19044
USA
Phone
Website
Email Address
Overview
Purpose-built to capture data electronically at the point of care, SureSource dramatically reduces development costs and timelines from Start to Submit.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ed Seguine
Chief Financial Officer
Scott Miltenberger
Chief Operating Officer
Jonathan Andrus
President
Doug Pierce
Browse more venture capital transactions:
Prev: 3/19/2015: BioPharmX venture capital transaction
Next: 3/19/2015: GelSight venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs